Salience Network Expansion May Be A Reliable Biomarker for Depression

A newly identified biomarker--an enlarged salience network in the brain--could dramatically change how depression is detected and treated. This network, responsible for regulating attention and switching between mental states, was found to be consistently larger in people with depression, regardless of symptom severity or treatment history.